Cerecin Received US FDA Clearance to Study CER-0001 under an Investigational New Drug (IND) Application for Infantile Spasms

Cerecin Inc. announced that they had received authorization from the US FDA for an IND application for CER-0001 in Infantile Spasm, also referred to as West Syndrome.